Literature DB >> 33837277

Deletion in COL4A2 is associated with a three-generation variable phenotype: from fetal to adult manifestations.

Gustavo Malinger1,2, Aviva Fattal-Valevski3,1, Moran Hausman-Kedem4,5, Liat Ben-Sira1,6, Debora Kidron1,7, Shay Ben-Shachar1,8,9, Rachel Straussberg1,8, Daphna Marom1,10, Penina Ponger1,10, Anat Bar-Shira10.   

Abstract

Genetic alterations in COL4A2 are less common than those of COL4A1 and their fetal phenotype has not been described to date. We describe a three-generation family with an intragenic deletion in COL4A2 associated with a prenatal diagnosis of recurrent fetal intracerebral hemorrhage (ICH), and a myriad of cerebrovascular manifestations. Exome sequencing, co-segregation analysis, and imaging studies were conducted on eight family members including two fetuses with antenatal ICH. Histopathological evaluation was performed on the terminated fetuses. An intragenic heterozygous pathogenic in-frame deletion; COL4A2, c.4151_4168del, (p.Thr1384_Gly1389del) was identified in both fetuses, their father with hemiplegic cerebral palsy (CP), as well as other family members. Postmortem histopathological examination identified microscopic foci of heterotopias and polymicrogyria. The variant segregated in affected individuals demonstrating varying degrees of penetrance and a wide phenotypic spectrum including periventricular venous hemorrhagic infarction causing hemiplegic CP, polymicrogyria, leukoencephalopathy, and lacunar stroke. We present radiographic, pathological, and genetic evidence of prenatal ICH and show, for what we believe to be the first time, a human pathological proof of polymicrogyria and heterotopias in association with a COL4A2 disease-causing variant, while illustrating the variable phenotype and partial penetrance of this disease. We highlight the importance of genetic analysis in fetal ICH and hemiplegic CP.
© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33837277      PMCID: PMC8560832          DOI: 10.1038/s41431-021-00880-3

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  45 in total

1.  Haemorrhagic stroke in term and late preterm neonates.

Authors:  Christie J Bruno; Lauren A Beslow; Char M Witmer; Arastoo Vossough; Lori C Jordan; Sarah Zelonis; Daniel J Licht; Rebecca N Ichord; Sabrina E Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-30       Impact factor: 5.747

2.  COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke.

Authors:  Marion Jeanne; Cassandre Labelle-Dumais; Jeff Jorgensen; W Berkeley Kauffman; Grazia M Mancini; Jack Favor; Valerie Valant; Steven M Greenberg; Jonathan Rosand; Douglas B Gould
Journal:  Am J Hum Genet       Date:  2011-12-29       Impact factor: 11.025

Review 3.  A review of genetic causes of ischemic and hemorrhagic stroke.

Authors:  Martijn Tonk; Joost Haan
Journal:  J Neurol Sci       Date:  2007-02-27       Impact factor: 3.181

4.  Cerebral palsy after maternal trauma in pregnancy.

Authors:  B Hayes; S Ryan; J B P Stephenson; M D King
Journal:  Dev Med Child Neurol       Date:  2007-09       Impact factor: 5.449

5.  COL4A2 mutation associated with familial porencephaly and small-vessel disease.

Authors:  Elly Verbeek; Marije E C Meuwissen; Frans W Verheijen; Paul P Govaert; Daniel J Licht; Debbie S Kuo; Cathryn J Poulton; Rachel Schot; Maarten H Lequin; Jeroen Dudink; Dicky J Halley; René I F de Coo; Jan C den Hollander; Renske Oegema; Douglas B Gould; Grazia M S Mancini
Journal:  Eur J Hum Genet       Date:  2012-02-15       Impact factor: 4.246

Review 6.  Antepartum fetal intracranial hemorrhage, predisposing factors and prenatal sonography: a review.

Authors:  D M Sherer; A Anyaegbunam; C Onyeije
Journal:  Am J Perinatol       Date:  1998-07       Impact factor: 1.862

7.  COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage.

Authors:  Linda S de Vries; Corine Koopman; Floris Groenendaal; Mary Van Schooneveld; Frans W Verheijen; Elly Verbeek; Theo D Witkamp; H Bart van der Worp; Grazia Mancini
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

Review 8.  The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.

Authors:  Marije E C Meuwissen; Dicky J J Halley; Liesbeth S Smit; Maarten H Lequin; Jan M Cobben; René de Coo; Jeske van Harssel; Suzanne Sallevelt; Gwendolyn Woldringh; Marjo S van der Knaap; Linda S de Vries; Grazia M S Mancini
Journal:  Genet Med       Date:  2015-02-26       Impact factor: 8.822

9.  COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humans.

Authors:  Cassandre Labelle-Dumais; David J Dilworth; Emily P Harrington; Michelle de Leau; David Lyons; Zhyldyz Kabaeva; M Chiara Manzini; William B Dobyns; Christopher A Walsh; Daniel E Michele; Douglas B Gould
Journal:  PLoS Genet       Date:  2011-05-19       Impact factor: 5.917

Review 10.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.

Authors:  Debbie S Kuo; Cassandre Labelle-Dumais; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

View more
  1 in total

1.  Genotyping arrays, population genetic studies and clinical implications.

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2021-11       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.